Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedChemComm

Showing results (151-160 of 801) with videos related to

Pageof 81
Sort By:
Medchemcomm|January 17, 2019
Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discoveryClinton G L Veale, Heinrich C Hoppe
Medchemcomm|January 17, 2019
Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1<i>H</i>)-one-3-carboxamide scaffoldAnna G Cooper, Caitlin R M Oyagawa, Jamie J Manning, et al.
Medchemcomm|December 21, 2018
Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxiaRonghua Yang, Caihong Guo
Medchemcomm|December 21, 2018
Towards identifying potent new hits for glioblastomaChris Sherer, Saurabh Prabhu, David Adams, et al.
Medchemcomm|December 21, 2018
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitorsBijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
Medchemcomm|December 21, 2018
Search for a 5-CT alternative. <i>In vitro</i> and <i>in vivo</i> evaluation of novel pharmacological tools: 3-(1-alkyl-1<i>H</i>-imidazol-5-yl)-1<i>H</i>-indole-5-carboxamides, low-basicity 5-HT<sub>7</sub> receptor agonistsGniewomir Latacz, Adam S Hogendorf, Agata Hogendorf, et al.
Medchemcomm|December 14, 2018
Targeting Brd4 for cancer therapy: inhibitors and degradersYingchao Duan, Yuanyuan Guan, Wenping Qin, et al.
Medchemcomm|December 14, 2018
Benzophenone: a ubiquitous scaffold in medicinal chemistryKhemchand Surana, Bharatkumar Chaudhary, Monika Diwaker, et al.
Medchemcomm|December 14, 2018
Design, synthesis, and anticancer activity evaluation of irreversible allosteric inhibitors of the ubiquitin-conjugating enzyme Ube2g2Chao Wang, Genbin Shi, Xinhua Ji
Medchemcomm|December 14, 2018
Novel tricyclic glycal-based <i>TRIB1</i> inducers that reprogram LDL metabolism in hepatic cellsMarek M Nagiec, Jeremy R Duvall, Adam P Skepner, et al.
Pageof 81

Showing results (151-160 of 801) with videos related to

Sort By:
Pageof 81
Medchemcomm|January 17, 2019
Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discoveryClinton G L Veale, Heinrich C Hoppe
Medchemcomm|January 17, 2019
Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1<i>H</i>)-one-3-carboxamide scaffoldAnna G Cooper, Caitlin R M Oyagawa, Jamie J Manning, et al.
Medchemcomm|December 21, 2018
Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxiaRonghua Yang, Caihong Guo
Medchemcomm|December 21, 2018
Towards identifying potent new hits for glioblastomaChris Sherer, Saurabh Prabhu, David Adams, et al.
Medchemcomm|December 21, 2018
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitorsBijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
Medchemcomm|December 21, 2018
Search for a 5-CT alternative. <i>In vitro</i> and <i>in vivo</i> evaluation of novel pharmacological tools: 3-(1-alkyl-1<i>H</i>-imidazol-5-yl)-1<i>H</i>-indole-5-carboxamides, low-basicity 5-HT<sub>7</sub> receptor agonistsGniewomir Latacz, Adam S Hogendorf, Agata Hogendorf, et al.
Medchemcomm|December 14, 2018
Targeting Brd4 for cancer therapy: inhibitors and degradersYingchao Duan, Yuanyuan Guan, Wenping Qin, et al.
Medchemcomm|December 14, 2018
Benzophenone: a ubiquitous scaffold in medicinal chemistryKhemchand Surana, Bharatkumar Chaudhary, Monika Diwaker, et al.
Medchemcomm|December 14, 2018
Design, synthesis, and anticancer activity evaluation of irreversible allosteric inhibitors of the ubiquitin-conjugating enzyme Ube2g2Chao Wang, Genbin Shi, Xinhua Ji
Medchemcomm|December 14, 2018
Novel tricyclic glycal-based <i>TRIB1</i> inducers that reprogram LDL metabolism in hepatic cellsMarek M Nagiec, Jeremy R Duvall, Adam P Skepner, et al.
Pageof 81